Biotechnology Institute I Mas D S.L.

The company funds research in diabetic foot ulcer management, with attention to patients who also have peripheral arterial disease. These studies center on plasma rich in growth factors in the context of impaired tissue repair.

• Foot ulcers in diabetic patients
• Peripheral arterial disease
• Wound healing

Its clinical interest in this area is directed toward ulcer evolution and recovery in complex metabolic and vascular disease.

Biotechnology Institute I Mas D S.L. also investigates low back pain associated with lumbar disc degeneration. The sponsored research evaluates regenerative approaches for pain relief and functional improvement in chronic spinal conditions.

• Low back pain
• Lumbar disc degeneration
• Quality of life

This area reflects an interest in persistent musculoskeletal symptoms where conventional pain management remains a clinical need.

Across its trial portfolio, the sponsor focuses on plasma rich in growth factors as a therapeutic platform in ophthalmology, wound care, and pain management. The funded studies explore its use in tissue repair and symptom reduction across distinct clinical settings.

• Plasma rich in growth factors (PRGF)
• Regenerative therapy
• Tissue repair

The research activity spans chronic conditions where biologically based treatments are being assessed for therapeutic benefit.